Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2011 - 2026)

Ani Pharmaceuticals (ANIP) has 16 years of Asset Utilization Ratio data on file, last reported at 0.65 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 23.37% year-over-year to 0.65; the trailing twelve-month figure through Mar 2026 stood at 0.65 (up 23.37% YoY), and the FY2025 full-year result was 0.65, up 15.5% from the prior year.
• Asset Utilization Ratio grew to 0.65 in Q1 2026, from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q1 2026 to a low of 0.3 in Q1 2022.
• A 5-year average of 0.5 and a median of 0.51 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio slipped 18.83% in 2022 and jumped 57.73% in 2023, its largest moves.
• Tracing ANIP's Asset Utilization Ratio over 5 years: stood at 0.42 in 2022, then climbed by 28.56% to 0.54 in 2023, then retreated by 11.95% to 0.48 in 2024, then gained by 29.82% to 0.62 in 2025, then increased by 4.06% to 0.65 in 2026.
• Business Quant data shows ANIP's Asset Utilization Ratio at 0.65 in Q1 2026, 0.62 in Q4 2025, and 0.6 in Q3 2025.